Immunovant, Inc. (IMVT)

CIK 1764013 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Immunovant, Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 20268-K0001764013-26-000106
Aug 28, 202640001764013-26-000103
Aug 21, 202640001973838-26-000007
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003481
Aug 6, 20268-K0001764013-26-000100
Aug 6, 202610-Q0001764013-26-000101
Jul 24, 202640001702969-26-000010
Jul 24, 202640001618670-26-000004
Jul 24, 202640001643071-26-000007
Jul 22, 2026DEFA14A0001764013-26-000093
Jul 22, 2026ARS0001764013-26-000094
Jul 22, 2026DEF 14A0001764013-26-000092
Jul 10, 202640001764013-26-000081
Jul 10, 202640001764013-26-000083
Jul 10, 202640001764013-26-000082
Jul 6, 202640001764013-26-000077
Jun 26, 20261440001950047-26-006532
Jun 26, 202640001764013-26-000075
Jun 26, 202640001764013-26-000072
Jun 26, 202640001764013-26-000074
Jun 26, 20261440001950047-26-006530
Jun 26, 202640001764013-26-000071
Jun 26, 202640001764013-26-000073
Jun 26, 20261440001950047-26-006543
Jun 26, 20261440001950047-26-006531